Lot · RR-TIRZ-2026Store 2–8°C · Keep Dry
Dual Agonist · GLP-1 / GIP
Tirzepatide
Dual incretin receptor peptide for metabolic signaling investigation.
- Formula
- C225H348N48O68
- Mol. Weight
- 4813.5 g/mol
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized
Available Configurations
Tirzepatide · 5mg
$50
Tirzepatide · 30mg
$80
/ Research Notes
Compound Profile
Tirzepatide is a synthetic 39-amino-acid analog acting on both the GLP-1 and GIP receptors. In-vitro assays reference it for incretin receptor selectivity, cAMP signaling, and downstream metabolic pathway analysis.
This compound is supplied strictly for in-vitro laboratory research. Not for human consumption, therapeutic, or diagnostic use.
HPLC Verified
≥99% purity
Mass-Spec Confirmed
MW verified
Sealed Vials
Tamper-evident packaging
Lyophilized
Sterile filled
